CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-13 | LAWLOR AUGUSTINE Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2019-06-13 | Williams Eddie Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2019-06-13 | Richard John P Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2019-06-13 | Hunt Andrea Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2019-06-13 | DESOUZA ERROL B Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2019-05-24 | Richard John P Director | Purchase | +1,000 | $8.03 | $8K | 1,216 |
| 2019-05-21 | USMAN NASSIM President & CEO | Exercise or conversion | +4,400 | $4.63 | $20K | 10,567 |
| 2019-05-21 | USMAN NASSIM President & CEO | Gift | −4,400 | 6,167 | ||
| 2019-05-21 | USMAN NASSIM President & CEO | Gift | +4,400 | 8,456 | ||
| 2019-05-21 | Levy Howard Chief Medical Officer | Exercise or conversion | +4,400 | $4.63 | $20K | 16,094 |
| 2019-05-21 | Levy Howard Chief Medical Officer | Gift | −16,094 | 16,094 | ||
| 2019-05-20 | USMAN NASSIM President & CEO | Exercise or conversion · Stock Option (Right to Buy) | −4,400 | 264,783 | ||
| 2019-05-20 | Levy Howard Chief Medical Officer | Exercise or conversion · Stock Option (Right to Buy) | −4,400 | 81,218 | ||
| 2019-04-01 | Williams Eddie Director | Grant or award | +1,364 | 3,036 | ||
| 2019-04-01 | LAWLOR AUGUSTINE Director | Grant or award | +2,414 | 5,146 | ||
| 2019-04-01 | Hunt Andrea Director | Grant or award | +717 | 1,528 | ||
| 2019-04-01 | DESOUZA ERROL B Director | Grant or award | +1,504 | 3,448 | ||
| 2019-02-11 | Payne Fletcher Chief Financial Officer | Grant or award | +1,002 | $7.04 | $7K | 3,731 |
| 2019-02-11 | USMAN NASSIM President & CEO | Grant or award | +350 | $7.04 | $2K | 6,167 |
| 2019-02-11 | Levy Howard Chief Medical Officer | Grant or award | +2,485 | $7.04 | $17K | 11,867 |
Page 18 of 24 · 471 trades